Syndax
  • Home
  • About Us
    • Back
    • About Us
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Vision, Mission, and Values
  • Pipeline
    • Back
    • Pipeline
    • SNDX-5613
    • Axatilimab
    • Entinostat
    • Publications & Meeting Presentations
  • Clinical Trials
    • Back
    • Clinical Trials
    • SNDX-5613 Clinical Trials
    • Axatilimab Clinical Trials
    • Compassionate Use
  • Patients & Caregivers
  • Investors
  • Contact Us
Syndax
Contact Us
  • About
  • Pipeline
  • Clinical Trials
  • Patients & Caregivers
  • Investors
  • Join Us

Determined to realize a future in which people with cancer live longer and better than ever before.


  • What is SNDX-5613?
  • What is axatilimab?
  • What is entinostat?
  • What clinical trials is Syndax currently conducting?
  • Who is on the leadership team at Syndax?
  • Where can I see your product pipeline?
  • What is the vision of Syndax?
  • Is Syndax hiring?
  • How can my organization collaborate with Syndax?
Pipeline
Leadership
Clinical Trials
Publications

03.01.21

Syndax to Announce Fourth Quarter and Year-end 2020 Financial Results and Host Conference Call and Webcast on March 8, 2021

02.24.21

Syndax Announces Participation at Two Upcoming Investor Conferences

12.18.20

Syndax Pharmaceuticals To Be Added to the NASDAQ Biotechnology Index

12.11.20

Syndax Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

© 2021 Syndax | Terms of Use | Privacy Policy | Site Map
  • About Us
  • Pipeline
  • Investors
  • Career Opportunities